Collect. Czech. Chem. Commun. 1998, 63, 480-506
https://doi.org/10.1135/cccc19980480

Towards an Effective Chemotherapy of Virus Infections: Therapeutic Potential of Cidofovir [(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine, HPMPC] for the Treatment of DNA Virus Infections

Erik De Clercq

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium

Individual author index pages


Other CCCC articles of these authors

  • Marcela Krečmerová, Antonín Holý, Alois Pískala, Graciela Andrei, Robert Snoeck, Jan Balzarini and Erik De Clercq
    New antiviral agent, 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: esters and base-modified derivatives
    Symposium Series 2008, Vol. 10, pp. 196–200 [Abstract]
    Published online 2015-10-30 18:37:33
  • Erik De Clercq
    Acyclic nucleoside phosphonates: An unfinished story
    2011, Vol. 76, Issue 7, pp. 829–842 [Abstract]
  • Erik De Clercq
    New Perspectives for the Treatment of HIV Infections
    1998, Vol. 63, Issue 4, pp. 449–479 [Abstract]
  • Michal Hocek, Milena Masojídková, Antonín Holý, Graciela Andrei, Robert Snoeck, Jan Balzarini and Erik De Clercq
    Synthesis and Antiviral Activity of Acyclic Nucleotide Analogues Derived from 6-(Aminomethyl)purines and Purine-6-carboxamidines
    1996, Vol. 61, Issue 10, pp. 1525–1537 [Abstract]
  • Ilse Verheggen, Nathalie Pillet, Arthur Van Aerschot, Erik De Clercq and Piet Herdewijn
    Synthesis and anti-herpesvirus activity of nucleosides with a 1,5-anhydrohexitol moiety
    1993, Vol. 58, Special Issue, pp. S64–S67 [Abstract]
  • Tadeusz Kulikowski, Jaroslaw Poznanski, Jan Balzarini, Arthur Van Aerschot and Erik De Clercq
    Synthesis, conformation and anti-HIV activity of 3'-substituted 2',3'-dideoxy-5-hydroxymethyluridines
    1993, Vol. 58, Special Issue, pp. S44–S46 [Abstract]
  • Arthur Van Aerschot, Liu Jie, Jan Balzarini, Erik De Clercq and Piet Herdewijn
    5'-O-Phosphonomethyl-2',3'-dideoxynucleosides: Synthesis and anti-HIV activity
    1990, Vol. 55, Special Issue, pp. S129–S132 [Abstract]
  • Hiromichi Tanaka, Masanori Baba, Masaru Ubasawa, Hideaki Takashima, Kouichi Sekiya, Tadashi Miyasaka, Issei Nitta, Richard T. Walker and Erik De Clercq
    The synthesis of novel 6-substituted acyclouridine derivatives which show specific inhibition of HIV-1
    1990, Vol. 55, Special Issue, pp. S89–S92 [Abstract]
  • Antonín Holý, Joachim König, Jiří Veselý, Dieter Cech, Ivan Votruba and Erik De Clercq
    5'-O-Alkyl-5-fluorouridines: Synthesis and biological activity
    1987, Vol. 52, Issue 6, pp. 1589–1608 [Abstract]
  • Antonín Holý, Ivan Votruba and Erik De Clercq
    Structure-activity studies on open-chain analogues of nucleosides: Inhibition of S-adenosyl-L-homocysteine hydrolase and antiviral activity 2. Acid open-chain analogues
    1985, Vol. 50, Issue 1, pp. 262–279 [Abstract]
  • Antonín Holý, Ivan Votruba and Erik De Clercq
    Structure-activity studies on open-chain analogues of nucleosides: Inhibition of S-adenosyl-L-homocysteine hydrolase and antiviral activity 1. Neutral open-chain analogues
    1985, Vol. 50, Issue 1, pp. 245–261 [Abstract]
  • Antonín Holý, Ivan Votruba and Erik De Clercq
    Synthesis and antiviral activity of stereoisomeric eritadenines
    1982, Vol. 47, Issue 5, pp. 1392–1407 [Abstract]
  • Antonín Holý and Erik De Clercq
    Preparation, spectral properties and biological activities of 5-bromo-6-methyl-2'-deoxyuridine and 5-iodo-6-methyl-2'-deoxyuridine
    1980, Vol. 45, Issue 8, pp. 2364–2370 [Abstract]